Last updated 2026-07-20
- Raised Undisclosed Round led by embARC Ventures, Nov 2025
- Raised grant, Feb 2023
Total raised
—
Last: Undisclosed Round 2025-12
Stage
Seed
Founded
2017
Headcount
6
HQ
Dimona, Israel
Sector
Health Tech & Life Sciences
About
Neshima Medical is a preclinical stage therapeutic company focused on revolutionizing respiratory medicine with its innovative Liquid Foam Therapy (LiFT™). The company's technology enables the topical and fast administration of high doses of therapeutics throughout the lungs, even through constricted and mucus-obstructed airways. Neshima Medical aims to treat severe lung diseases such as pneumonia, Acute Respiratory Distress Syndrome (ARDS), COPD, and asthma, with the potential for lung regeneration. Their LiFT RapidHeal™ technology can deliver significantly higher concentrations of drugs directly into the lungs compared to standard-of-care, and the foam's unique fluid properties can reach infections beyond mucus obstructions.
Funding history · 2 rounds · — total
2025-11
Undisclosed Round
Undisclosed
★ embARC VenturesRunYoung Technology Transfer CenterTechnion Research & Development Foundation
2023-02
Grant
Undisclosed
Headcount over time
From 6 (2021-04) to 6 (2026-01) · +0 (+0%) · 4 points · source: Finder history + radar grounding
Q&A
- What is Neshima Medical's primary focus?
- Neshima Medical is developing life-saving treatments for severe lung diseases using its patented LiFT™ foam-based delivery platform.
- When was Neshima Medical founded?
- Neshima Medical was founded in April 2020.
- How many employees does Neshima Medical currently have?
- Neshima Medical has 1-10 employees.
- What is Neshima Medical's lead application for its LiFT™ platform?
- Neshima Medical's lead application for the LiFT™ platform is a regenerative cell therapy for COPD.
- Has Neshima Medical received any grant funding?
- Yes, Neshima Medical received a grant from the Israel Innovation Authority in March 2023.
- Which investor participated in Neshima Medical's funding round in December 2025?
- embARC Ventures participated in Neshima Medical's funding round in December 2025.
- What is the estimated market Neshima Medical is targeting?
- Neshima Medical is targeting a $10 billion U.S. market with a B2B model.
- Who are the co-founders of Neshima Medical?
- The co-founders of Neshima Medical are Yan Ostrovski (Co-founder & CEO), Ramy Fishler (Co-founder & CTO), Avital Frenkel (Co-founder & Chief Systems Architect), and Josué Sznitman (Co-founder & Chief Scientific Officer).
Team · 5
Dr. Yan Ostrovski
Founder · Co-founder & CEO
Avital Frenkel
Founder · Co-founder & Chief Systems Architect
Dr. Ramy Fishler
Founder · Co-founder & CTO
Prof. Josué Sznitman
Founder · Co-founder & Chief Scientific Officer
Dr. Yoav Medan
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
patientsmedical-devicesrespiratoryhealthcare-providershospitalsmedical-technologiesdrug-deliverypatent-pending
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neshimamedical.com/ |
|---|---|
| linkedin.com/company/neshima-medical-ltd |
Identifiers & details
| Legal name | Neshima Medical Ltd. |
|---|---|
| Founded | 2017 |
| Employees (exact) | 6 |
| Offices | Dimona |
Radar intelligence
Web history (Wayback)
| Domain | neshimamedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516182136 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-04-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | שיקמה 25 דימונה |